Article info

Anti-VEGF-resistant subretinal fluid is associated with better vision and reduced risk of macular atrophy

Authors

  1. Correspondence to Dr Marco A Zarbin, Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, USA; zarbin{at}rutgers.edu
View Full Text

Citation

Zarbin MA, Hill L, Maunz A, et al
Anti-VEGF-resistant subretinal fluid is associated with better vision and reduced risk of macular atrophy

Publication history

  • Received December 22, 2020
  • Revised April 7, 2021
  • Accepted April 30, 2021
  • First published May 26, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.